Medical management of heavy menstrual bleeding: a comprehensive review of the literature - PubMed (original) (raw)
Review
Medical management of heavy menstrual bleeding: a comprehensive review of the literature
Johannes Bitzer et al. Obstet Gynecol Surv. 2015 Feb.
Abstract
Importance: Heavy menstrual bleeding (HMB) is a common complaint among reproductive-aged women, which negatively affects their health as well as their social, professional, and family lives. Modern medical management usually provides effective control of HMB irrespective of the underlying cause. Surgical interventions should be reserved for women with significant pelvic pathology and those unresponsive to medical therapy.
Objective: The aim of this review was to provide a comprehensive summary of the efficacy and safety of available medical treatments of HMB.
Evidence acquisition: A comprehensive MEDLINE and EMBASE literature search was undertaken using selected terms associated with HMB to identify clinical studies published before March 20, 2013, that reported changes in menstrual blood loss in women receiving medical intervention.
Results: The effectiveness of treatments to reduce HMB due to endometrial dysfunction in descending order was as follows: (1) the levonorgestrel-releasing intrauterine system (LNG-IUS) (initial release rate of 20 μg of LNG per 24 hours), (2) combined hormonal contraceptives (oral or transvaginal), (3) tranexamic acid, and (4) long-course oral progestogens (≥3 weeks per cycle). The LNG-IUS was found to reduce HMB due to some structural causes (leiomyomas and adenomyosis). The reduction in menstrual blood loss achieved with nonsteroidal anti-inflammatory drugs and short-course oral progestogens (≤14 days per cycle) is less impressive but may be sufficient for women who have marginally increased blood loss.
Conclusions and relevance: For women not seeking pregnancy, the LNG-IUS is the first-line medical therapy for HMB, with combined hormonal contraceptives as second choice. For other women, fewer effective options exist.
Similar articles
- Progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Bofill Rodriguez M, Lethaby A, Jordan V. Bofill Rodriguez M, et al. Cochrane Database Syst Rev. 2020 Jun 12;6(6):CD002126. doi: 10.1002/14651858.CD002126.pub4. Cochrane Database Syst Rev. 2020. PMID: 32529637 Free PMC article. - Cyclical progestogens for heavy menstrual bleeding.
Bofill Rodriguez M, Lethaby A, Low C, Cameron IT. Bofill Rodriguez M, et al. Cochrane Database Syst Rev. 2019 Aug 14;8(8):CD001016. doi: 10.1002/14651858.CD001016.pub3. Cochrane Database Syst Rev. 2019. PMID: 31425626 Free PMC article. - Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis.
Bofill Rodriguez M, Dias S, Jordan V, Lethaby A, Lensen SF, Wise MR, Wilkinson J, Brown J, Farquhar C. Bofill Rodriguez M, et al. Cochrane Database Syst Rev. 2022 May 31;5(5):CD013180. doi: 10.1002/14651858.CD013180.pub2. Cochrane Database Syst Rev. 2022. PMID: 35638592 Free PMC article. Review. - Combined hormonal contraceptives for heavy menstrual bleeding.
Lethaby A, Wise MR, Weterings MA, Bofill Rodriguez M, Brown J. Lethaby A, et al. Cochrane Database Syst Rev. 2019 Feb 11;2(2):CD000154. doi: 10.1002/14651858.CD000154.pub3. Cochrane Database Syst Rev. 2019. PMID: 30742315 Free PMC article. - The medical management of abnormal uterine bleeding in reproductive-aged women.
Bradley LD, Gueye NA. Bradley LD, et al. Am J Obstet Gynecol. 2016 Jan;214(1):31-44. doi: 10.1016/j.ajog.2015.07.044. Epub 2015 Aug 5. Am J Obstet Gynecol. 2016. PMID: 26254516 Review.
Cited by
- Levonorgestrel-releasing intrauterine device to treat abnormal uterine bleeding; not one treatment option fits all.
Atak Z, Rahımlı Ocakoğlu S, Ocakoğlu G. Atak Z, et al. J Turk Ger Gynecol Assoc. 2023 Dec 6;24(4):246-251. doi: 10.4274/jtgga.galenos.2023.2022-12-12. J Turk Ger Gynecol Assoc. 2023. PMID: 38054416 Free PMC article. - Comparative study of the levonorgestrel intrauterine system and laparoscopic hysterectomy for the treatment of heavy menstrual bleeding in enlarged uteri.
Depes DB, Mata MVMD, Pereira AMG, Martins JA, Araújo MP, Lopes RGC, Bella ZIKJ. Depes DB, et al. Einstein (Sao Paulo). 2023 Apr 17;21:eAO0033. doi: 10.31744/einstein_journal/2023AO0033. eCollection 2023. Einstein (Sao Paulo). 2023. PMID: 37075458 Free PMC article. - Management of heavy menstrual bleeding in women with bleeding disorders in a tertiary care center.
Kuthiala S, Grabell J, Relke N, Hopman WM, Silva M, Jamieson MA, James P. Kuthiala S, et al. Res Pract Thromb Haemost. 2023 Mar 13;7(3):100119. doi: 10.1016/j.rpth.2023.100119. eCollection 2023 Mar. Res Pract Thromb Haemost. 2023. PMID: 37065843 Free PMC article. - Reproductive changes among women in their 40s: A cross-sectional study.
Lindh I, Skjeldestad FE, Heikinheimo O, Hognert H, Lidegaard Ø, Bergh C, Gemzell-Danielsson K. Lindh I, et al. Acta Obstet Gynecol Scand. 2022 Feb;101(2):248-255. doi: 10.1111/aogs.14302. Epub 2022 Jan 5. Acta Obstet Gynecol Scand. 2022. PMID: 34988971 Free PMC article. - The need to screen for anemia in exercising women.
Dugan C, Scott C, Abeysiri S, Baikady RR, Richards T. Dugan C, et al. Medicine (Baltimore). 2021 Oct 1;100(39):e27271. doi: 10.1097/MD.0000000000027271. Medicine (Baltimore). 2021. PMID: 34596123 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources